Lilly Endowment Is First to Hit $100 Billion Mark on Stock Surge

Eli Lilly & Co.’s stock has reached new highs in recent days, becoming the first pharmaceutical company to hit a $1 trillion valuation. The surge has also lifted the founding family’s private foundation to a record $100 billion in assets.

The Lilly Endowment is the drugmaker’s largest shareholder with 92.5 million shares, according to its latest Securities and Exchange Commission filing. As of 3:25 p.m. in New York, the foundation’s stake was worth about $102 billion.